@FierceMedDev: ICYMI: FDA gives nod to newest pelvic mesh product, despite ongoing safety issues. Article | Follow @FierceMedDev
@VarunSaxena2: ICYMI: Bard VP touts new study of its Lutonix drug-coated balloon to fight PAD. Article | Follow @VarunSaxena2
@EmilyWFierce: EU stands by crackdown on drug spending in Ireland. FiercePharma story | Follow @EmilyWFierce
> The Wall Street Journal puts a spotlight on innovation for the elderly in a story about designer and inventor Barbara Beskind who suggests, among other things, wearable air bags to prevent hip fractures and translation devices to be used between healthcare providers and patients. Article
> VentureWire ran a story suggesting that a new initiative by the Japanese government to work more closely with Silicon Valley in industries including medical devices could aid the sector. Article
> Toshiba America Medical Systems and Merge Healthcare ($MRGE) have partnered to combine Merge's cardiology and hemodynamic monitoring solutions with the Toshiba portfolio of vascular X-ray systems. More
Biotech News
@FierceBiotech: Facing off rivals, Merck looks to expand CINV label on positive PhIII Emend study. Story | Follow @FierceBiotech
@JohnCFierce: These guys at Spinifex are smart--Giant Novartis downs a pain med in $200M-plus buyout of tiny Spinifex. More | Follow @JohnCFierce
@DamianFierce: From BIO last week, here's $QURE CEO Aldag talking about $CLDN, $AAVL and the future of gene therapy. Listen | Follow @DamianFierce
> AMAG snags Cord Blood Registry for $700M. Item
> Egalet's pain pill is tougher to abuse than Purdue's morphine tablet, study shows. Report
Pharma News
@FiercePharma: Novartis shells out $200M-plus for Spinifex and its mid-stage pain drug. FiercePharmaMarketing item | Follow @FiercePharma
@EricPFierce: ICYMI from FiercePharmaManufacturing: France's TxCell closes its plant at ANSM urging to avoid contamination. Story | Follow @EricPFierce
@CarlyHFierce: Can Allergan make double-chin drug pay off? Maybe, but slowly, analysts say. More | Follow @CarlyHFierce
> Will Mylan boost its Perrigo bid? New securities filing suggests it won't. More
> Tougher regulations force Indian drugmakers to invest or divest. Article
Animal Health News
> Egg prices soar, menu items dropped in wake of historic avian flu. More
> Investors erase Zoetis gains as questions emerge about Valeant's pursuit. Report
> Sorrento nabs key FDA designation for nonopiate drug to treat bone pain in dogs. Item
> Scottish scientists design piglets to resist African swine fever. Story
> Henry Schein expands global reach, taking majority stake in Denmark's Kruuse. Article
Biotech IT News
> Eisai strikes extensive multiyear IT outsourcing deal with Accenture. News
> Google steps up wearables plan with clinical trial-focused wristband. Story
> Analyst: R&D time pressures mean clinical trial tech and automation are finally taking off. More
> Google to pair its cloud-computing power with Broad's analytic tools. Article
> SEC starts pursuit of biotech-focused hacking ring. Report
Pharma Marketing News
> Novartis shells out $200M-plus for Spinifex and its mid-stage pain drug. News
> Should Bristol-Myers cut payer deals to boost melanoma combo over one-drug treatments? More
> Will pharma jump into an EHR app store near you? Don't count on it anytime soon. Story
> Nuedexta maker Avanir taps actor Danny Glover to shed light on little-known neurological condition. Article